These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 22606007)

  • 1. Phages and HIV-1: from display to interplay.
    Delhalle S; Schmit JC; Chevigné A
    Int J Mol Sci; 2012; 13(4):4727-4794. PubMed ID: 22606007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-human immunodeficiency virus type 1 human monoclonal antibodies that bind discontinuous epitopes in the viral glycoproteins can identify mimotopes from recombinant phage peptide display libraries.
    Boots LJ; McKenna PM; Arnold BA; Keller PM; Gorny MK; Zolla-Pazner S; Robinson JE; Conley AJ
    AIDS Res Hum Retroviruses; 1997 Dec; 13(18):1549-59. PubMed ID: 9430247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mimotopes selected by biopanning with high-titer HIV-neutralizing antibodies in plasma from Chinese slow progressors.
    Zhang X; Han X; Dai D; Bao M; Zhang Z; Zhang M; Bice T; Zhao M; Cao Y; Shang H
    Braz J Infect Dis; 2012; 16(6):510-6. PubMed ID: 23141970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection and immune recognition of HIV-1 MPER mimotopes.
    Wieczorek L; Peachman K; Steers N; Schoen J; Rao M; Polonis V; Rao V
    Virology; 2020 Nov; 550():99-108. PubMed ID: 32980676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape.
    Wibmer CK; Gorman J; Ozorowski G; Bhiman JN; Sheward DJ; Elliott DH; Rouelle J; Smira A; Joyce MG; Ndabambi N; Druz A; Asokan M; Burton DR; Connors M; Abdool Karim SS; Mascola JR; Robinson JE; Ward AB; Williamson C; Kwong PD; Morris L; Moore PL
    PLoS Pathog; 2017 Jan; 13(1):e1006074. PubMed ID: 28076415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a new epitope for HIV-neutralizing antibodies in the gp41 membrane proximal external region by an Env-tailored phage display library.
    Zhou M; Meyer T; Koch S; Koch J; von Briesen H; Benito JM; Soriano V; Haberl A; Bickel M; Dübel S; Hust M; Dietrich U
    Eur J Immunol; 2013 Feb; 43(2):499-509. PubMed ID: 23180650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
    J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage-displayed mimotopes recognizing a biologically active anti-HIV-1 gp120 murine monoclonal antibody.
    Gómez-Román VR; Cao C; Bai Y; Santamaría H; Acero G; Manoutcharian K; Weiner DB; Ugen KE; Gevorkian G
    J Acquir Immune Defic Syndr; 2002 Oct; 31(2):147-53. PubMed ID: 12394792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1.
    Gohain N; Tolbert WD; Acharya P; Yu L; Liu T; Zhao P; Orlandi C; Visciano ML; Kamin-Lewis R; Sajadi MM; Martin L; Robinson JE; Kwong PD; DeVico AL; Ray K; Lewis GK; Pazgier M
    J Virol; 2015 Sep; 89(17):8840-54. PubMed ID: 26085162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of peptide mimics of HIV-1 epitope recognized by neutralizing antibody VRC01.
    Chikaev AN; Bakulina AY; Burdick RC; Karpenko LI; Pathak VK; Ilyichev AA
    PLoS One; 2015; 10(3):e0120847. PubMed ID: 25785734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.
    Moulard M; Phogat SK; Shu Y; Labrijn AF; Xiao X; Binley JM; Zhang MY; Sidorov IA; Broder CC; Robinson J; Parren PW; Burton DR; Dimitrov DS
    Proc Natl Acad Sci U S A; 2002 May; 99(10):6913-8. PubMed ID: 11997472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of two scFv-Fc antibodies from an HIV controller selected on soluble HIV-1 Env complexes: a neutralizing V3- and a trimer-specific gp41 antibody.
    Trott M; Weiβ S; Antoni S; Koch J; von Briesen H; Hust M; Dietrich U
    PLoS One; 2014; 9(5):e97478. PubMed ID: 24828352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of a novel neutralizing antibody targeting the CD4-binding site of HIV-1 gp120.
    Qiao Y; Man L; Qiu Z; Yang L; Sun Y; He Y
    Antiviral Res; 2016 Aug; 132():252-61. PubMed ID: 27387828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purified complexes of HIV-1 envelope glycoproteins with CD4 and CCR5(CXCR4): production, characterization and immunogenicity.
    Xiao X; Phogat S; Shu Y; Phogat A; Chow YH; Wei OL; Goldstein H; Broder CC; Dimitrov DS
    Vaccine; 2003 Oct; 21(27-30):4275-84. PubMed ID: 14505910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface.
    Huang J; Kang BH; Pancera M; Lee JH; Tong T; Feng Y; Imamichi H; Georgiev IS; Chuang GY; Druz A; Doria-Rose NA; Laub L; Sliepen K; van Gils MJ; de la Peña AT; Derking R; Klasse PJ; Migueles SA; Bailer RT; Alam M; Pugach P; Haynes BF; Wyatt RT; Sanders RW; Binley JM; Ward AB; Mascola JR; Kwong PD; Connors M
    Nature; 2014 Nov; 515(7525):138-42. PubMed ID: 25186731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of antibody landscape and viral envelope escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies.
    Dieltjens T; Heyndrickx L; Willems B; Gray E; Van Nieuwenhove L; Grupping K; Vanham G; Janssens W
    Retrovirology; 2009 Dec; 6():113. PubMed ID: 20003438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic properties of the HIV envelope on virions in solution.
    Ray K; Mengistu M; Yu L; Lewis GK; Lakowicz JR; DeVico AL
    J Virol; 2014 Feb; 88(3):1795-808. PubMed ID: 24284318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Resolution Mapping of Human Norovirus Antigens via Genomic Phage Display Library Selections and Deep Sequencing.
    Huang W; Soeung V; Boragine DM; Hu L; Prasad BVV; Estes MK; Atmar RL; Palzkill T
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33055250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverse Immunology Approach to Define a New HIV-gp41-Neutralizing Epitope.
    Dorgham K; Pietrancosta N; Affoune A; Lucar O; Bouceba T; Chardonnet S; Pionneau C; Piesse C; Sterlin D; Guardado-Calvo P; Karoyan P; Debré P; Gorochov G; Vieillard V
    J Immunol Res; 2019; 2019():9804584. PubMed ID: 31019982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide ligands selected with CD4-induced epitopes on native dualtropic HIV-1 envelope proteins mimic extracellular coreceptor domains and bind to HIV-1 gp120 independently of coreceptor usage.
    Dervillez X; Klaukien V; Dürr R; Koch J; Kreutz A; Haarmann T; Stoll M; Lee D; Carlomagno T; Schnierle B; Möbius K; Königs C; Griesinger C; Dietrich U
    J Virol; 2010 Oct; 84(19):10131-8. PubMed ID: 20660187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.